Skip to main content
Clinical Trials/NCT01176578
NCT01176578Active, not recruitingNot Applicable

Exercise Training, CACs, and Vascular Function in Older Veterans With IGT (Impaired Glucose Tolerance)

Baltimore VA Medical Center1 site in 1 country70 target enrollmentStarted: July 1, 2011Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Active, not recruiting
Enrollment
70
Locations
1
Primary Endpoint
Endothelial progenitor cell number

Study Overview

Brief Summary

The discovery of the role of endothelial progenitor cells (EPCs) and their involvement in the cardiovascular complications of type 2 diabetes (T2DM) would quickly have a significant impact on the millions of Americans who have T2DM. This project is designed to 1) determine the mechanisms underlying EPC dysfunction in older, sedentary adults with T2DM compared those with normal glucose metabolism and impaired glucose metabolism, and 2) determine if aerobic exercise training is an efficacious therapy for EPC dysfunction in T2DM, and whether improvement in EPC number and function translates to improved endothelial function, increased capillarization, and improved glucose metabolism in T2DM.

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
None

Eligibility Criteria

Ages
50 Years to 80 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Age 50-80
  • •Non-smoker
  • •If woman, postmenopausal >1 year

Exclusion Criteria

  • •History of heart disease or stroke
  • •Poorly controlled hypertension or dyslipidemia
  • •Kidney or Liver diseases

Arms & Interventions

T2DM

Experimental

Type 2 Diabetes Mellitus

Intervention: Aerobic Exercise Training (Other)

IGT

Experimental

Impaired Glucose Tolerance

Intervention: Aerobic Exercise Training (Other)

NGT

Active Comparator

Normal Glucose Tolerance

Intervention: Aerobic Exercise Training (Other)

Outcomes

Primary Outcomes

Endothelial progenitor cell number

Time Frame: 6-month

Skeletal muscle capillarization

Time Frame: 6-month

Endothelial progenitor cell number

Time Frame: Baseline

Skeletal muscle capillarization

Time Frame: Baseline

Secondary Outcomes

  • Cardiorespiratory Fitness(6-month)
  • Cardiorespiratory Fitness(Baseline)

Investigators

Sponsor Class
Fed
Responsible Party
Principal Investigator
Principal Investigator

Steven J. Prior, Ph.D.

Assistant Professor

Baltimore VA Medical Center

Study Sites (1)

Loading locations...

Similar Trials